Drug Trial Radar · NCT00004064
Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Last checked: Nov 19, 2026Latest source record: Nov 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
102
Planned (sponsor's estimate)
Start
Nov 1998
Primary completion
Not stated
Sponsor
- Lead sponsor
- AltaRexIndustry
- Sponsor type
- Industry
- First posted
- Aug 5, 2004
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells. PURPOSE: Randomized phase II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have ovarian, fallopian tube, or peritoneal cancer.
Conditions
- Fallopian Tube Cancer
- Ovarian Cancer
- Primary Peritoneal Cavity Cancer
Interventions
oregovomabBiological
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
16 sites in 2 countries. Site status is shown where the registry gives one.
Gynecologic Oncology Associates
Newport Beach, California
Lee Memorial Health System
Fort Myers, Florida
Walt Disney Memorial Cancer Institute
Orlando, Florida
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
Indiana University Cancer Center
Indianapolis, Indiana
University of Iowa Hospitals and Clinics
Iowa City, Iowa
Mercy Medical Center, Inc.
Baltimore, Maryland
Barnes-Jewish Hospital
St Louis, Missouri
St. John's Mercy Medical Center
St Louis, Missouri
University of Oklahoma College of Medicine
Oklahoma City, Oklahoma
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Palmetto Richland Memorial Hospital
Columbia, South Carolina
Texas Oncology, P.A.
Dallas, Texas
Cancer Center, University of Virginia HSC
Charlottesville, Virginia
Riverside Regional Medical Center
Newport News, Virginia
Ottawa Regional Cancer Center - General Division
Ottawa, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.